|
tbar.gif
Click
here to
submit entries
|
|
|
Heparin Mimic
Found in Baxter Product |
March
6, 2008--Heparin sold and
recalled by Baxter International, which has been linked to 19 deaths
and numerous illnesses, contained a possibly counterfeit ingredient.
Tests showed that as much as 20% of the product’s active
ingredient was a heparin mimic combined with the real drug. Heparin
batches associated with illnesses, all of which were produced with
ingredients made in China, were found to contain the contaminant
while batches not linked to illnesses proved to be untainted.
However, it hasn’t been proven that the contaminant is responsible
for the adverse events. The
New York Times (Free registration required)
For
background, see: More
Deaths Possibly Linked to Baxter’s Heparin;
China
Says Importing Countries Bear Responsibility for Drug Checks;
White
House Wants to Widen FDA Authority Over Imports;
FDA
Failed to Inspect Chinese Maker of Heparin Ingredient Linked to
Deaths; House Democrat Calls for FDA Commissioner's Resignation;
Log
Jam of Foreign Plant Inspections for FDA;
FDA
To Beef up Its Presence Abroad.
|
|
|
Genstruct: Patience, Persistence, and Payoff
By John Russell |
|
Finding the right business model for systems biology (SB) technology providers has been challenging — that’s hardly a new theme in biotech.
Click
here
|
|
|
